HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ABCA4
ATP binding cassette subfamily A member 4
Chromosome 1 Β· 1p22.1
NCBI Gene: 24Ensembl: ENSG00000198691.14HGNC: HGNC:34UniProt: P78363
323PubMed Papers
25Diseases
0Drugs
1,468Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
endoplasmic reticulumretinal metabolic processphospholipid translocationATP hydrolysis activitysevere early-childhood-onset retinal dystrophyStargardt diseasecone-rod dystrophy 3age-related macular degeneration
✦AI Summary

ABCA4 is a photoreceptor-specific ATP-binding cassette transporter localized to rod and cone outer segment disc membranes 1. Its primary function is to actively transport N-retinylidene-phosphatidylethanolamine (N-Ret-PE) conjugates across disc membranes in an ATP-dependent manner, functioning as a flippase that moves retinoid-phospholipid adducts from the lumen to the cytoplasmic leaflet 1. This transport mechanism efficiently clears all-trans-retinal and excess 11-cis-retinal from photoreceptors, preventing accumulation of toxic bisretinoid compounds and lipofuscin 1. ABCA4 exhibits intrinsic ATPase activity and may display GTPase activity influenced by lipid environment and retinoid presence 1. Loss-of-function mutations cause Stargardt disease (STGD1), the most common juvenile macular dystrophy, with prevalence of approximately 1 in 8,000-10,000 2. ABCA4 is the most frequently mutated gene in inherited retinal diseases, accounting for 26.3% of solved cases in a large cohort 3. Over 1,200 pathogenic variants have been identified with variable penetrance and geographical distribution 4. Patients with STGD1 present with progressive central vision loss, lipofuscin accumulation, and macular degeneration, with disease severity influenced by variant classification (null versus non-null), onset age, and genetic modifiers 5. No approved treatment currently exists, though multiple therapeutic strategies targeting retinoid metabolism, oxidative stress, and genetic repair are under investigation 4.

Sources cited
1
ABCA4 structure, function as N-Ret-PE transporter, localization to disc membranes, ATP-dependent mechanism, and role in Stargardt disease pathogenesis
PMID: 34954332
2
Stargardt disease prevalence, typical presentation, age of onset, and clinical features including fundus appearance
PMID: 30578500
3
ABCA4 is the most frequently mutated gene in inherited retinal diseases (26.3% of solved cases) in a large Italian cohort
PMID: 36460718
4
Over 1,200 ABCA4 pathogenic variants, genetic heterogeneity, variable penetrance, and current therapeutic landscape for STGD1
PMID: 40725253
5
Genotype-phenotype correlations in ABCA4-RD, including disease severity based on null versus non-null variants and clinical manifestations
PMID: 33301772
Disease Associationsβ“˜25
severe early-childhood-onset retinal dystrophyOpen Targets
0.84Strong
Stargardt diseaseOpen Targets
0.84Strong
cone-rod dystrophy 3Open Targets
0.83Strong
age-related macular degenerationOpen Targets
0.79Strong
retinitis pigmentosa 19Open Targets
0.78Strong
Cone rod dystrophyOpen Targets
0.73Strong
retinitis pigmentosaOpen Targets
0.70Moderate
cone-rod dystrophyOpen Targets
0.68Moderate
ABCA4-related retinopathyOpen Targets
0.68Moderate
macular degenerationOpen Targets
0.62Moderate
Retinal dystrophyOpen Targets
0.59Moderate
Leber congenital amaurosisOpen Targets
0.59Moderate
retinopathyOpen Targets
0.57Moderate
Macular dystrophyOpen Targets
0.54Moderate
genetic disorderOpen Targets
0.54Moderate
Stargardt disease 3Open Targets
0.54Moderate
cone dystrophyOpen Targets
0.53Moderate
autosomal recessive retinitis pigmentosaOpen Targets
0.52Moderate
isolated macular dystrophyOpen Targets
0.52Moderate
optic atrophyOpen Targets
0.51Moderate
Cone-rod dystrophy 3UniProt
Fundus flavimaculatusUniProt
Macular degeneration, age-related, 2UniProt
Retinitis pigmentosa 19UniProt
Stargardt disease 1UniProt
Pathogenic Variants1,468
NM_000350.3(ABCA4):c.4537dup (p.Gln1513fs)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy|Retinitis pigmentosa|Retinitis pigmentosa 19|Macular dystrophy|Cone-rod dystrophy 3|Retinal dystrophy|Cone-rod dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2026β†’ Residue 1513
NM_000350.3(ABCA4):c.4532C>A (p.Pro1511His)Likely pathogenic
not provided|Stargardt disease|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2026β†’ Residue 1511
NM_000350.3(ABCA4):c.4195G>T (p.Glu1399Ter)Pathogenic
Severe early-childhood-onset retinal dystrophy|ABCA4-related disorder|Retinal dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1399
NM_000350.3(ABCA4):c.1819G>A (p.Gly607Arg)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy|Stargardt disease|Retinal dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 607
NM_000350.3(ABCA4):c.2488G>T (p.Glu830Ter)Likely pathogenic
ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 830
NM_000350.3(ABCA4):c.6329G>A (p.Trp2110Ter)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy|Retinal dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 2110
NM_000350.3(ABCA4):c.5460+1G>APathogenic
not provided|Retinitis pigmentosa|Stargardt disease|Autosomal recessive retinitis pigmentosa|Retinal dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025
NM_000350.3(ABCA4):c.4895dup (p.Asn1632fs)Pathogenic
Cone-rod dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1632
NM_000350.3(ABCA4):c.6568C>T (p.Gln2190Ter)Pathogenic
not provided|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 2190
NM_000350.3(ABCA4):c.4720G>T (p.Glu1574Ter)Pathogenic
not provided|Cone-rod dystrophy|Stargardt disease|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1574
NM_000350.3(ABCA4):c.3328+2T>APathogenic
not provided|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025
NM_000350.3(ABCA4):c.2879del (p.Ala960fs)Pathogenic
not provided|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 960
NM_000350.3(ABCA4):c.2345G>A (p.Trp782Ter)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy;Age related macular degeneration 2;Cone-rod dystrophy 3;Retinitis pigmentosa 19|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 782
NM_000350.3(ABCA4):c.4577C>T (p.Thr1526Met)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy|Retinitis pigmentosa 19|Inborn genetic diseases|Stargardt disease|Retinal dystrophy|Age related macular degeneration 2|Cone-rod dystrophy 3;Retinitis pigmentosa 19;Age related macular degeneration 2;Severe early-childhood-onset retinal dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1526
NM_000350.3(ABCA4):c.3210_3211dup (p.Ser1071fs)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy|Bietti crystalline corneoretinal dystrophy|Retinal dystrophy|ABCA4-related disorder|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1071
NM_000350.3(ABCA4):c.5753A>T (p.Asp1918Val)Pathogenic
not provided|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1918
NM_000350.3(ABCA4):c.5584G>C (p.Gly1862Arg)Pathogenic
not provided|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 1862
NM_000350.3(ABCA4):c.45G>A (p.Trp15Ter)Pathogenic
not provided|Severe early-childhood-onset retinal dystrophy|Retinal dystrophy|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 15
NM_000350.3(ABCA4):c.4352+1G>APathogenic
Severe early-childhood-onset retinal dystrophy|not provided|Retinal dystrophy|Stargardt disease|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025
NM_000350.3(ABCA4):c.6416G>C (p.Arg2139Pro)Pathogenic
ABCA4-related disorder|not provided|ABCA4-related retinopathy
β˜…β˜…β˜…β˜†2025β†’ Residue 2139
View on ClinVar β†—
Related Genes
AIPL1Protein interaction93%GUCY2DProtein interaction88%RPGRIP1Protein interaction86%EYSProtein interaction86%PCAREProtein interaction84%ELOVL4Protein interaction84%
Tissue Expression6 tissues
Liver
100%
Brain
32%
Bone Marrow
31%
Ovary
20%
Lung
20%
Heart
18%
Gene Interaction Network
Click a node to explore
ABCA4AIPL1GUCY2DRPGRIP1EYSPCAREELOVL4
PROTEIN STRUCTURE
Preparing viewer…
PDB7M1Q Β· 2.92 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.79LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.70 [0.62–0.79]
RankingsWhere ABCA4 stands among ~20K protein-coding genes
  • #1,026of 20,598
    Most Researched323 Β· top 5%
  • #19of 5,498
    Most Pathogenic Variants1,468 Β· top 1%
  • #6,455of 17,882
    Most Constrained (LOEUF)0.79
Genes detectedABCA4
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy.
PMID: 36460718
Sci Rep Β· 2022
1.00
2
Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs.
PMID: 28118664
Invest Ophthalmol Vis Sci Β· 2017
0.90
3
Stargardt Disease.
PMID: 30578500
Adv Exp Med Biol Β· 2018
0.80
4
Personalized genetic counseling for Stargardt disease: Offspring risk estimates based on variant severity.
PMID: 35120629
Am J Hum Genet Β· 2022
0.70
5
Clinical and genetic analysis of the ABCA4 gene associated retinal dystrophy in a large Chinese cohort.
PMID: 33301772
Exp Eye Res Β· 2021
0.60